股票市场 | Island Pharma获埃博拉药紧急使用批准大涨
2026-07-07 01:10:22
据彭博社报道，澳大利亚Island Pharmaceuticals Ltd.表示，其实验性抗病毒药物galidesivir已获监管及伦理批准，可在乌干达为感染Bundibugyo型埃博拉病毒的患者紧急使用；公司股价一度上涨47%。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
美股上涨，港股ADR跌15点报23601点Next article：
AI趋势 | 华尔街日报：OpenAI等向初创企业提供算力优惠
